Impact of CT-Determined Sarcopenia and Body Composition on Survival Outcome in Patients with Advanced-Stage High-Grade Serous Ovarian Carcinoma

Impact of CT-Determined Sarcopenia and Body Composition on Survival Outcome in Patients with Advanced-Stage High-Grade Serous Ovarian Carcinoma

This study aimed to investigate the impact of sarcopenia and body composition on survival outcomes in Korean patients with advanced-stage high-grade serous ovarian carcinoma (HGSOC). We retrospectively identified patients diagnosed with and treated for International Federation of Gynecology and Obst...

Full description

Bibliographic Details
Main Authors:	Se Ik Kim, Taek Min Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jeong Yeon Cho, Yong Sang Song
Format:	Article
Language:	English
Published:	MDPI AG 2020-02-01
Series:	Cancers
Subjects:	ovarian neoplasms high-grade serous carcinoma sarcopenia body composition prognosis survival
Online Access:	https://www.mdpi.com/2072-6694/12/3/559

Similar Items

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
by: Se Ik Kim, et al.
Published: (2020-03-01)

Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma
by: Suhyun Hwangbo, et al.
Published: (2021-04-01)

Cell Origins of High-Grade Serous Ovarian Cancer
by: Jaeyeon Kim, et al.
Published: (2018-11-01)

Digital pathology-based study of cell- and tissue-level morphologic features in serous borderline ovarian tumor and high-grade serous ovarian cancer
by: Jun Jiang, et al.
Published: (2021-01-01)

Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes
by: Min-Hwan Sohn, et al.
Published: (2021-07-01)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
by: Renan Ribeiro e Ribeiro, et al.
Published: (2021-05-01)

The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
by: Tingting Zhu, et al.
Published: (2020-06-01)

Proteome profiling of low grade serous ovarian cancer
by: Haniyeh Bashi zadeh fakhar, et al.
Published: (2019-07-01)

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
by: Se Ik Kim, et al.
Published: (2019-05-01)

Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
by: Michalis Liontos, et al.
Published: (2021-03-01)

Sarcopenia: Clinical implications in ovarian cancer, diagnosis, etiology, and management
by: Aeran Seol, et al.
Published: (2020-12-01)

A Computed Tomography-Based Radiomic Prognostic Marker of Advanced High-Grade Serous Ovarian Cancer Recurrence: A Multicenter Study
by: Wei Wei, et al.
Published: (2019-04-01)

Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan
by: Kuan-Chong Chao, et al.
Published: (2013-03-01)

Space-and Time-Resolved Metabolomics of a High-Grade Serous Ovarian Cancer Mouse Model
by: Botros, A., et al.
Published: (2022)

EGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value
by: Mayada S. Farrag, et al.
Published: (2021-06-01)

Durable response to hormonal therapy in a patient with rapidly progressive low-grade serous ovarian cancer: A case report
by: Catherine H. Watson, et al.
Published: (2020-08-01)

<i>USP19</i> and <i>RPL23</i> as Candidate Prognostic Markers for Advanced-Stage High-Grade Serous Ovarian Carcinoma
by: Haeyoun Kang, et al.
Published: (2021-08-01)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
by: Maho Shimizu, et al.
Published: (2021-06-01)

An immune-related gene pairs signature predicts overall survival in serous ovarian carcinoma
by: Zhang L, et al.
Published: (2019-08-01)

Combined CCNE1 high‐level amplification and overexpression is associated with unfavourable outcome in tubo‐ovarian high‐grade serous carcinoma
by: Angela MY Chan, et al.
Published: (2020-10-01)

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
by: Berchuck, A., et al.
Published: (2022)

Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response
by: Kankan Cao, et al.
Published: (2021-01-01)

The Development and Validation of a CT-Based Radiomics Nomogram to Preoperatively Predict Lymph Node Metastasis in High-Grade Serous Ovarian Cancer
by: Hui-zhu Chen, et al.
Published: (2021-08-01)

Bioinformatic profiling identifies a platinum‐resistant–related risk signature for ovarian cancer
by: Ce Wu, et al.
Published: (2020-02-01)

Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)
by: Young Shin Chung, et al.
Published: (2019-04-01)

Radiomics Analysis of PET and CT Components of 18F-FDG PET/CT Imaging for Prediction of Progression-Free Survival in Advanced High-Grade Serous Ovarian Cancer
by: Xihai Wang, et al.
Published: (2021-04-01)

BRCA and early events in the development of high grade serous ovarian cancer
by: Sophia HL George, et al.
Published: (2014-01-01)

Gene Expression Subtyping Reveals Immune alterations:TCGA Database for Prognosis in Ovarian Serous Cystadenocarcinoma
by: Chunxia Feng, et al.
Published: (2021-09-01)

Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
by: Huimei Zhou, et al.
Published: (2020-04-01)

Progesterone Prevents High-Grade Serous Ovarian Cancer by Inducing Necroptosis of p53-Defective Fallopian Tube Epithelial Cells
by: Na-Yiyuan Wu, et al.
Published: (2017-03-01)

Importance of serous intraepithelial ovarian tubal carcinomas in the occurrence of "high-grade" serous carcinomas and / or peritoneal serous carcinomas of unknown primary origin.
by: I. S. Shponka, et al.
Published: (2020-04-01)

Cytology positive pericardial effusion causing tamponade in patients with high grade serous carcinoma of the ovary
by: Joni Kooy, et al.
Published: (2020-08-01)

Survival Analysis and Prognosis for Patients with Serous and Mucinous Borderline Ovarian Tumors: 14-Year Experience from a Tertiary Center in Iran
by: Katayoun Ziari, et al.
Published: (2015-04-01)

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
by: Huan Wu, et al.
Published: (2019-12-01)

Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report
by: Chiaki Kubo, et al.
Published: (2018-06-01)

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer
by: Andreea Newtson, et al.
Published: (2021-04-01)

Assessment of Significant Pathway Signaling and Prognostic Value of GNG11 in Ovarian Serous Cystadenocarcinoma
by: Jiang MM, et al.
Published: (2021-06-01)

Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
by: Kyung Jin Eoh, et al.
Published: (2020-03-01)

Pathogenic Heteroplasmic Somatic Mitochondrial DNA Mutation Confers Platinum-Resistance and Recurrence of High-Grade Serous Ovarian Cancer
by: Ni J, et al.
Published: (2020-11-01)

Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma
by: Yingwei Hu, et al.
Published: (2020-10-01)